Developer of female non-hormonal contraceptives. The company develops a sperm motility-inhibiting probiotic agent which prevents fertilization and also protects against sexually transmitted diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Grant | 04-Jun-2012 | $997K | Completed | Startup | ||
2. Grant | 01-May-2010 | 00000 | Completed | Startup | ||
1. Angel (individual) | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Rachel Teitelbaum Ph.D | Founder & Co-Chief Executive Officer | ||
David Zakai | Chief Operating Officer, Vice President, Business Development & Chief Business Officer |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |